Alpa Laboratories Limited (NSE:ALPA)

Market Cap	1.21B -35.0%
Revenue (ttm)	1.11B +0.5%
Net Income	42.22M -83.9%
EPS	2.11 -83.2%
Shares Out	21.04M
PE Ratio	27.35
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,674
Open	59.00
Previous Close	58.73
Day's Range	57.42 - 59.68
52-Week Range	46.10 - 93.85
Beta	0.91
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Alpa Laboratories

Alpa Laboratories Limited engages in the manufacture and sale of drugs and chemicals in India. It offers ethical, generic, and over the counter medicines. The company provides tablets, capsules, injections, syrups, ointments, creams, eye drops, and other dosage forms for human and veterinary healthcare, as well as aquaculture products, including probiotics, deodorizer, minerals, feed supplements, and disinfectant. The company was founded in 1967 and is based in Indore, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Employees: 457
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALPA

Financial Performance

In fiscal year 2026, Alpa Laboratories's revenue was 1.06 billion, a decrease of -5.91% compared to the previous year's 1.12 billion. Earnings were 150.10 million, a decrease of -23.04%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 7, 2026

Data Sources Report a data error